353810 — Easy Bio Share Price
- KR₩168bn
- KR₩321bn
- KR₩384bn
- 64
- 78
- 96
- 94
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 5.22 | ||
PEG Ratio (f) | 0.2 | ||
EPS Growth (f) | 35.06% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2 | ||
Price to Tang. Book | 9.36 | ||
Price to Free Cashflow | 7.8 | ||
Price to Sales | 0.44 | ||
EV to EBITDA | 8.53 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 12.98% | ||
Return on Equity | 26.72% | ||
Operating Margin | 7.84% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 88,123.27 | 129,457.81 | 155,557.1 | 165,385.09 | 384,330.91 | 437,000 | 458,700 | 44.51% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | +4.29 | -16.01 | +70.29 | +38.66 | +55.96 | +6.29 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Easy Bio Inc is a Korea-based company mainly engaged in the manufacture and sale of additives and pig feed. The Company mainly manufactures and sells feed, feed ingredients, and animal feed additives. The Company sells its products in domestic and overseas markets such as the United States, Colombia, China, Vietnam and Thailand.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 1st, 2020
- Public Since
- June 5th, 2020
- No. of Shareholders
- 16,641
- No. of Employees
- 122
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
Korea Exchange - KOSDAQ
- Shares in Issue
- 31,972,120

- Address
- SEOUL, 06253
- Web
- https://www.easybio.co.kr/
- Phone
- +82 25019988
- Auditors
- Echon Accounting Corp.
Upcoming Events for 353810
Similar to 353810
Asia Seed Co
Korea Exchange - KOSDAQ
Bifido Co
Korea Exchange - KOSDAQ
BL PharmTech
Korea Exchange - KOSDAQ
ByOn Co
Korea Exchange - KOSDAQ
Cherrybro Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 20:21 UTC, shares in Easy Bio are trading at KR₩5,240. This share price information is delayed by 15 minutes.
Shares in Easy Bio last closed at KR₩5,240 and the price had moved by +27.18% over the past 365 days. In terms of relative price strength the Easy Bio share price has outperformed the FTSE Developed Asia Pacific Index by +28.64% over the past year.
The overall consensus recommendation for Easy Bio is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Easy Bio dividend yield is 3.82% based on the trailing twelve month period.
Last year, Easy Bio paid a total dividend of KR₩200, and it currently has a trailing dividend yield of 3.82%. We do not have any data on when Easy Bio is to next pay dividends.
We do not have data on when Easy Bio is to next pay dividends. The historic dividend yield on Easy Bio shares is currently 3.82%.
To buy shares in Easy Bio you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩5,240, shares in Easy Bio had a market capitalisation of KR₩168bn.
Here are the trading details for Easy Bio:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 353810
Based on an overall assessment of its quality, value and momentum Easy Bio is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Easy Bio. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +60.94%.
As of the last closing price of KR₩5,240, shares in Easy Bio were trading +20.97% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Easy Bio PE ratio based on its reported earnings over the past 12 months is 5.22. The shares last closed at KR₩5,240.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Easy Bio's directors